SEC Form 4 · accession 0001805624-26-000004
Pulmonx Corp · LUNG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glendon E. French III
Officer — President and CEO · Director
Period of report
Sep 1, 2026
Accepted (ET)
Sep 3, 2026 · 6:23 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001127537
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 1, 2026 | S | 4,098 | $2.26 | D | 1,175,720 | D | |
| Common Stock | Sep 1, 2026 | S | 37,784 | $2.26 | D | 1,137,936 | D | |
| Common StockF4 | holding | — | — | — | 918,198 | I | By trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023.
- F2Includes 1,656 shares acquired by the reporting person under the Issuer's 2020 Employee Stock Purchase Plan on August 14, 2026.
- F3These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on December 1, 2025.
- F4The shares are held by the Glendon E French & Gayle French Trustees French Family Rev Trust UA DTD 08/29/2012, of which the reporting person and his spouse are trustees and beneficiaries.